| [1] |
Egami S, Yamagami J, Amagai M. Autoimmune bullous skin diseases, pemphigus and pemphigoid[J]. J Allergy Clin Immunol, 2020,145(4):1031⁃1047. DOI: 10.1016/j.jaci.2020. 02.013.
|
| [2] |
Lim W, Le Gal G, Bates SM, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: diagnosis of venous thromboembolism[J]. Blood Adv, 2018,2(22):3226⁃3256. DOI: 10.1182/bloodadvances. 2018024828.
|
| [3] |
Sho Y, Sakai T, Matsuda⁃Hirose H, et al. Thromboembolism and bleeding in patients with autoimmune blistering disease[J]. Clin Exp Dermatol, 2022,47(12):2255⁃2260. DOI: 10.1111/ced. 15375.
|
| [4] |
Cugno M, Marzano AV, Bucciarelli P, et al. Increased risk of venous thromboembolism in patients with bullous pemphigoid. The INVENTEP (INcidence of VENous ThromboEmbolism in bullous Pemphigoid) study[J]. Thromb Haemost, 2016,115(1):193⁃199. DOI: 10.1160/TH15⁃04⁃0309.
|
| [5] |
Leshem YA, Atzmony L, Dudkiewicz I, et al. Venous thromboembolism in patients with pemphigus: a cohort study[J]. J Am Acad Dermatol, 2017,77(2):256⁃260. DOI: 10.1016/j.jaad. 2017.01.059.
|
| [6] |
金芳草, 尹光文, 李旭阳, 等. 寻常型天疱疮合并静脉血栓5例临床分析[J]. 中国皮肤性病学杂志, 2021,35(6):643⁃645. DOI: 10.13735/j.cjdv.1001⁃7089.202010074.
|
| [7] |
王玥, 严煜林. 寻常型天疱疮合并急性肺栓塞危险因素分析[J]. 中国麻风皮肤病杂志, 2021,37(9):568⁃570. DOI: 10. 12144/zgmfskin202109568.
|
| [8] |
扈容英, 杨兵艳, 张晓蕊, 等. 大疱性类天疱疮患者发生静脉血栓栓塞症6例临床分析[J]. 中国皮肤性病学杂志, 2022,36(5):546⁃549. DOI: 10.13735/j.cjdv.1001⁃7089.202110049.
|
| [9] |
Joly P, Horvath B, Patsatsi Α, et al. Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)[J]. J Eur Acad Dermatol Venereol, 2020,34(9):1900⁃1913. DOI: 10.1111/jdv.16752.
|
| [10] |
中华医学会皮肤性病学分会, 中国医师协会皮肤科医师分会. 自身免疫性表皮下大疱病诊疗共识(2022)[J]. 中华皮肤科杂志, 2022,55(1):1⁃11. DOI: 10.35541/cjd.20210532.
|
| [11] |
Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score[J]. J Thromb Haemost, 2010,8(11):2450⁃2457. DOI: 10.1111/j.1538⁃7836.2010.04044.x.
|
| [12] |
Kridin K, Kridin M, Amber KT, et al. The risk of pulmonary embolism in patients with pemphigus: a population⁃based large⁃scale longitudinal study[J]. Front Immunol, 2019,10:1559. DOI: 10.3389/fimmu.2019.01559.
|
| [13] |
Chen CL, Wu CY, Lyu YS, et al. Association between bullous pemphigoid and risk of venous thromboembolism: a nationwide population⁃based cohort study[J]. J Dermatol, 2022,49(8):753⁃761. DOI: 10.1111/1346⁃8138.16412.
|
| [14] |
Schneeweiss MC, Merola JF, Wyss R, et al. Venous thromboembolism in patients with bullous pemphigoid[J]. JAMA Dermatol, 2023,159(7):750⁃756. DOI: 10.1001/jamadermatol. 2023.1461.
|
| [15] |
Chen TL, Huang WT, Loh CH, et al. Risk of incident venous thromboembolism among patients with bullous pemphigoid or pemphigus vulgaris: a nationwide cohort study with meta⁃analysis[J]. J Am Heart Assoc, 2023,12(17):e029740. DOI: 10.1161/JAHA.123.029740.
|
| [16] |
Marzano AV, Tedeschi A, Spinelli D, et al. Coagulation activation in autoimmune bullous diseases[J]. Clin Exp Immunol, 2009,158(1):31⁃36. DOI: 10.1111/j.1365⁃2249.2009. 03989.x.
|
| [17] |
Levi M, van der Poll T. Two⁃way interactions between inflammation and coagulation[J]. Trends Cardiovasc Med, 2005,15(7):254⁃259. DOI: 10.1016/j.tcm.2005.07.004.
|
| [18] |
Marzano AV, Tedeschi A, Fanoni D, et al. Activation of blood coagulation in bullous pemphigoid: role of eosinophils, and local and systemic implications[J]. Br J Dermatol, 2009,160(2):266⁃272. DOI: 10.1111/j.1365⁃2133.2008.08880.x.
|
| [19] |
Tedeschi A, Marzano AV, Lorini M, et al. Eosinophil cationic protein levels parallel coagulation activation in the blister fluid of patients with bullous pemphigoid[J]. J Eur Acad Dermatol Venereol, 2015,29(4):813⁃817. DOI: 10.1111/jdv.12464.
|
| [20] |
Folsom AR, Lutsey PL, Heckbert SR, et al. Serum albumin and risk of venous thromboembolism[J]. Thromb Haemost, 2010,104(1):100⁃104. DOI: 10.1160/TH09⁃12⁃0856.
|
| [21] |
Arques S. Human serum albumin in cardiovascular diseases[J]. Eur J Intern Med, 2018,52:8⁃12. DOI: 10.1016/j.ejim.2018.04.014.
|
| [22] |
Rossetto V, Barbar S, Vedovetto V, et al. Physicians' compliance with the Padua Prediction Score for preventing venous thromboembolism among hospitalized medical patients[J]. J Thromb Haemost, 2013,11(7):1428⁃1430. DOI: 10.1111/jth.12258.
|
| [23] |
Darzi AJ, Repp AB, Spencer FA, et al. Risk⁃assessment models for VTE and bleeding in hospitalized medical patients: an overview of systematic reviews[J]. Blood Adv, 2020,4(19):4929⁃4944. DOI: 10.1182/bloodadvances.2020002482.
|
| [24] |
Heit JA. Cardiovascular endocrinology: risk of venous thromboembolism with glucocorticoids[J]. Nat Rev Endocrinol, 2013,9(7):387⁃388. DOI: 10.1038/nrendo.2013.107.
|
| [25] |
Orsi FA, Lijfering WM, Geersing GJ, et al. Glucocorticoid use and risk of first and recurrent venous thromboembolism: self⁃controlled case⁃series and cohort study[J]. Br J Haematol, 2021,193(6):1194⁃1202. DOI: 10.1111/bjh.17388.
|